A human hepatoma cell line constitutively expressing proteins of hepatitis C virus (HCV) was established by transfection with cDNA encoding part of the virus nonstructural (NS) genome region. Proteins consistent with authentic processing at NS3/NS4A, NS4A/NS4B and NS4B/NS5A were identified. Pulse-chase experiments indicated that the cleavage between NS3 and NS4A occurred first and cleavage at other sites followed.
Introduction
Detailed analyses of hepatitis C virus (HCV), the main causative agent of non-A, non-B hepatitis and also known to be closely associated with the development of hepatocellular carcinoma, have long been hampered by the unavailability of in vitro systems to support its replication Kuo et al., 1989; Shimizu et al., 1992) . Although HCV is thought to replicate principally in hepatocytes, little is known about the tissue-specific processing of the viral proteins and intracellular restrictions on viral gene expression. We have therefore tried to establish human liver cell lines constitutively expressing HC¥ proteins by transfecting HCV cDNAs in order to study virus-cell interactions during the course of viral replication.
It has, however, been generally difficult to obtain stable transfectants of hepatocytes. The efficiency of hepatocyte colony formation using drug resistance genes is extremely low. We recently found that the EF321 * Author for correspondence. Fax +81 3 5285 1161. e-mail tmiyamur@nih.go.jp t Present address: Department of Microbiology, College of Natural Science, Chang Won National University, Chang-Wong, Korea.
promoter, derived from the gene encoding the human polypeptide chain elongation factor Is, is useful for obtaining such stable transfectants from human liver cells (Uetsuki et al., 1989; Kim et al., 1993) . By the use of this promoter, a human hepatoma cell line constitutively expressing non-structural (NS) proteins of HCV was established. We characterized the proteolytic processing of these proteins. In addition, as the first step to study the interaction of host and viral proteins, surface markers of this clone were analysed. (Kubo et al., 1989; Takeuchi et al., 1990a, b) . To construct pUC3269, the clone was introduced into a Sinai site of the pUC119, in which a BamHI site was replaced with a 10 nt NotI linker. Consequently at the N terminus of the expressed tNS2 protein six extra amino acids (aa) were expected. To terminate readthrough translation, a termination codon was introduced into the clone by site-directed mutagenesis (Kunkel, 1985) and codon 2212 was changed from CAG to TAG. The mutant DNA fragment was recloned into the parent DNA between the EcoRI site at nt 6687 and the XbaI site at nt 7085. To generate the initiator ATG, a NotI-XbaI fragment of 3.9 kb from pUC3269 was ligated with NotI XbaI-digested pSR816X (Matsuura et al., 1992) . A PstI-XbaI fragment of 3.9 kb of this plasmid was made blunt with the Klenow fragment of DNA polymerase I and introduced into the SwaI site of cdEF321swxneo. Plasmid pcEF3269neo was constructed by removing the spacer region and cos sites of cdEF3269neo using EcoRV.
Cell culture. HepG2 cells were maintained in Dulbecco's modified Eagle's medium (DMEM)-F12 (Gibco) supplemented with 10 % fetal bovine serum, 2 mM-glutamine, 100 IU of penicillin per ml and 100 mg of streptomycin per ml. Cells in a 60 mm dish coated with collagen (Corning) were transfected with 10 pg of each plasmid (pcEF321 swxneo and pcEF3269neo), respectively (previously linearized with EcoRV according to the method of Chen & Okayama, 1987 with some modifications). Transformants were selected in DMEM-F12 medium containing 500 lag of G418 (Gibco) per ml. G418-resistant colonies were isolated, replated twice for purification and designated Hepswx and Hep3269neo, respectively.
Antibodies. Immunological reagents used to characterize the expressed HCV proteins were as follows: human serum of a patient with chronic hepatitis C infection (SK); anti-NS5A polyclonal antibodies produced in rabbits immunized with purified recombinant proteins of NS5A (aa2119 to 2359) expressed in Escheriehia coli (Suzuki et al., unpublished results) ; anti-NS3 monoclonal antibody (MAb), provided by M. Kohara (Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan); anti-NS4A MAb, provided by A. Takamizawa (Research Foundation for Microbial Diseases of Osaka University, Kagawa, Japan).
Western blotting. For Western blotting, cells were lysed in SDS sample buffer (50 mM-Tri~HC1 pH 6.8, 2 % SDS, 10 % glycerol, 5 % 2-mercaptoethanol) and sonicated. Lysates from 10 n cells were separated by SDS-PAGE according to the method of Laemmli (1970) . Proteins were electrotransferred onto Immobilon transfer membranes (Millipore). The membrane was treated with blocking buffer containing 3% non-fat dried milk in PBS and incubated with HCV-specific antibodies. Antige~antibody complexes were visualized using antirabbit immunoglobulin labelled with alkaline phosphatase (Tago).
Immunoprecipitation. For immunoprecipitation, cells in a 35 mm dish were labelled with 20 ~tCi of TRAN35S-label (ICN) for 3 h after 1 h of starvation in methionine and cysteine-free Eagle's MEM. Labelled cells were lysed with TNE buffer (10 mM-Tris-HC1 pH 7.8, 150 mM-NaC1, 1 mM-EDTA, 1% NP40, 1 mM-PMSF, 10 pg of aprotinin per ml). Lysates were immunoprecipitated with the SK serum or Ts 145 (anti-CD26 MAb) and rabbit anti-mouse IgG (Serotec). Protein A Sepharose CL-4B (Pharmacia-LKB) was used to collect the immune complexes. The precipitated antigens were separated by 10% SDS-PAGE and the radioactivity was measured in a Bio-lmage model BAS2000 analyser (Fuji Photo Film).
Immunofluorescence analysis. Coverslips with cells were washed twice in PBS and fixed with 4 % paraformaldehyde in PBS/0.05 % Tween-20 for 10 min at room temperature. After being washed in PBS, they were soaked in 10 mM-glycine. Fixed cells were incubated with anti-NS3 (dilution of 1/100) MAb, anti-NS4A (dilution of 1/600) MAb, rabbit anti-NS5A (dilution of 1/100) Ab or Ts145 (dilution of 1/100) in PBS/0"5% BSA for 1 h at 37 °C. After incubation the cells were washed and FITC-conjugated goat anti-mouse Ig or goat anti-rabbit Ig (Tago) were added at 1/200 dilution in PBS.
Puls~chase experiment. For the pulse-chase experiment, cells were labelled with 50 laCi of TRANZSS-label (ICN) for 15 min after 1 h of starvation in methionine and cysteine-free Eagle's MEM and chased using medium without label for 5, 10, 20, 30, 60, 120 and 240 min. Labelled cells were lysed with TNE buffer. Lysates were immunoprecipitated with the SK serum and protein A Sepharose CL-4B was used to collect the immune complexes. The precipitated antigens were separated by 10-20 % gradient SDS-PAGE, and the radioactivity was measured in a Bio-Image model BAS2000 analyser.
Nuclease S1 protection. The procedure for nuclease S1 protection was described previously (Saito et al., 1986a; Suzuki et al., 1989 ). An EeoRV/EeoRI fragment of 6.2 kb was derived from pcEF3269neo ( Fig. 1 a) , containing the EF321 promoter (an EeoRV site is located upstream of the N terminus of the EF321 promoter) and almost the entire insert of the HCV cDNA (an EeoRI site at nt 6687). The 5'-end of this fragment (EeoRI site) was labelled with T4 polynucleotide kinase and [y_32p] ATP. Cytoplasmic RNA (125 lag) extracted from the cells was hybridized at 62 °C for 3 h with 40 ng of 3~P-labelled probe DNA, digested with 500 U of nuclease S1 (Takara Shuzo) per ml and analysed on a 1.2 % alkaline gel. X-Omat film (Kodak) was used for autoradiography.
Surface marker analysis. Surface markers were analysed as follows. Cells were trypsinized and washed twice with PBS. For the direct immunofluorescence method, FITC-conjugated MAbs were used. Nu-N1 (CD10), MCS-2 (CD13), MCS-1 (CD15) and Nu-TfR1 (CD63) were obtained from Nichirei. JML-H14 (CD14) was a gift from A. Hara (JML, Fukuoka, Japan). For the indirect immunofluorescence method, W6/32 (Class I; obtained from Dainihon Seiyaku), Ts145 (CD26; a gift from R. Ueda, Aichi Cancer Center, Nagoya, Japan), K20 (CD29; a gift from L. Boomsell, Hospital Saint-Louis, Paris, France), D1 : EF (CD49f; a gift from J. M. Wang, Christie Hospital, Manchester, UK), H5C6 (CD63; a gift from J. Hildreth, Johns Hopkins University, Baltimore, Md, USA) and anti-FAS (CD95; a gift from S. Yonehara, JT, Yokohama, Japan) were used as primary antibodies. FITC-conjugated goat anti-mouse Ig (Tago) was used as secondary antibody. Each primary antibody was classified into CD antigen at the Fifth International Workshop on Human Leukocyte Differentiation Antigens. Cells were incubated with each antibody for 30 min at 4 °C. Stained cells were analysed by the FACScan flow cytometry system (Becton Dickinson Immunocytometry Systems).
Results

Establishment of a human liver cell line constitutively expressing HCV non-structural proteins
The expression plasmid cdEF321swxneo was constructed as shown in Fig. l(a) . To construct pcEF3269neo, HCV cDNA covering from the Cterminal portion of NS2 to the N-terminal half of NS5A (Fig. 1 b) linearized with EcoRV according to the method of Chen & Okayama (1987) with some modifications. Transformants were selected in DMEM containing 500 lag of G418 per ml. Five G418-resistant colonies were cloned and named Hepswx and Hep3269neo, respectively. The expressed HCV proteins were analysed by Western blotting and immunoprecipitation. As shown in Fig. 2 , we identified an uncleared protein of truncated NS2 (tNS2) and NS3 proteins of approximately M r 77000 (77K protein) (Fig. 2a) . This value is reasonable since the NS2 cDNA (predicted to encode a 52 aa protein) is not cleaved at the site between NS2 and NS3 (NS2/3). This is consistent with the data of Grakoui et aL (1993a) ; Hijikata et al. (1993a) and Suzuki et aL (unpublished results) . The NS4A protein of M r 8000 (Fig. 2b ) and the N-terminal halfofNS5A (240 an) of M~ 29000 (Fig. 2b) were also detected. Each processed product was also detected by the serum SK (Fig. 2 c) and their sizes were consistent with those reported previously (Grakoui et al., 1993c; Manabe et al., 1994) .
Intracellular localization of expressed HCV nonstructural proteins was examined by indirect immunofluorescence analysis. As shown in Fig. 3 , diffuse cytoplasmic staining of each HCV non-structural protein was observed in Hep3269 cells. No fluorescence was observed in Hepswx cells. Samples were also fixed in icecold methanol for 10 rain. These two fixation methods gave identical results (data not shown).
The constitutive expression of such processed HCV proteins has been maintained after 30 passages over 6 months (data not shown).
Proteolytic processing of the HCV non-structural proteins
The time course of processing of these HCV nonstructural proteins was then examined. As shown in Fig.  4 , processed tNS2-NS3, NS4A, tNS5A and two unprocessed precursor proteins of tNS2-NS3-NS4-tNS5A, and of NS4A-NS4B-tNS5A were detected. The NS4A and tNS5A proteins appeared when the unprocessed proteins disappeared. However, the tNS2-NS3 protein was detected immediately after the chase. Although non-structural HCV proteins are considered to be generated from the precursor polyprotein by processing, there was an alternative possibility that these proteins are synthesized from aberrantly spliced RNA in this expression system. To examine this possibility, RNA from Hep3269 cells was analysed by a nuclease S1 protection experiment. The predicted size of the band after digestion with nuclease S1 was shorter than the size of the labelled DNA probe because the transcript of the EF321 promoter is spliced. As shown in Fig. 5 , no bands were detected except for the expected band of 3"5 kb covering the entire HCV cDNA included in the probe DNA. Each non-structural HCV protein described here was thus generated from the precursor protein by processing.
Analysis of surface markers in Hep3269 cells
To study the interaction of viral and cellular proteins in Hep3269 cells, surface markers, which are characterized as differentiation antigens of leukocytes, were analysed by flow cytometry. As shown in Table 1 , CD26 was highly expressed on Hep3269 cells. In contrast, no significant change was found for other surface antigens tested. To investigate the upregulated expression of the CD26 antigen, an immunoprecipitation analysis was performed. As expected, CD26 antigen of M r 110000 was detected (Fig. 6 ). This result was further confirmed by indirect immunofluorescence analysis. Most of the cells showed strong CD26 immunoreaction with anti-CD26 MAb (Fig. 7) . Similar results were also obtained in the other four Hep3269 cell clones with the same cDNA insert (data not shown). The fluorescence was mainly located on the cell membrane, supporting the result of flow cytometric analysis. No fluorescence was observed in parent HepG2 cells or a HepG2 clone constitutively expressing structural HCV proteins (data not shown).
Discussion
This is the first report of the establishment of a liver cell line constitutively expressing HCV proteins. We have established other liver cell lines stably expressing structural proteins of HCV by the same methods (Harada et al., unpublished results) .
The size of each processed product was consistent with that reported previously. To examine the time course of processing in this system, the cells were analysed by pulse-chase experiment. The appearance of the NS4A and the tNS5A proteins was associated with the disappearance of unprocessed proteins. However, the tNS2-NS3 protein was detected immediately after the chase. It is known that the NS3 region of the HCV genome has a functional domain of the viral proteinase that cleaves at the NS3/NS4A, NS4A/NS4B, NS4B/ NS5A and NS5A/NS5B sites, respectively, and the NS3 proteinase acts in cis at its C terminus to process itself from the polyprotein precursor (Grakoui et al., 1993b; Tomei et al., 1993; Failla et al., 1994) . The cleavages at NS4A/NS4B and NS4B/NS5A were detected at the same time after the NS3/NS4A was cleaved. This is consistent with the previous notion that they are cleaved in trans by NS3 product. Previous experiments in vitro indicated that the NS5A sequence was necessary for the cleavage at NS4A/NS4B (Hijikata et al., 1993 b) . Present experiments described above, however, indicated that the partial NS5A sequence (240 aa) was sufficient for this cleavage. To examine whether there was aberrantly spliced RNA in this system, an RNA from the Hep3269 cells was analysed by the S1 nuclease protection method. The results indicated that the non-structural HCV proteins described here were generated from the precursor protein by processing. The serine proteinase responsible for processing the non-structural proteins of HCV is recognized as a possible target for novel antiviral agents. The cell line established in this study provides a useful system for screening compounds targeted against the proteinase. Although HCV infection is implicated in development of hepatic cirrhosis and hepatocellular carcinoma (Bruix et al., 1989; Colombo et al., 1989; Saito et al., 1990; Nishioka et al., 1991) , the mechanism is at present totally unknown. The constitutive expression of HCV proteins in hepatocytes is consequently useful for studying the intracellular events induced by HCV proteins and ultimately the pathogenesis of HCV infection.
As a first approach to study the virus--cell interaction in this system, we analysed surface markers on Hep3269 cells using flow cytometry. It should be noted that significantly upregulated CD26 levels in the clone were observed. CD26 has dipeptidyl peptidase IV (DPP IV, EC3.4.14.5) enzyme activity and is known to cleave Nterminal dipeptides from polypeptides with either Lproline or L-alanine at penultimate positions in its extracellular domain (Ulmer et al., 1990) . It is also a T cell activation antigen (Dang et al., 1990) and is directly associated with adenosine deaminase (Kameoka et al., 1993) or Tat of human immunodeficiency virus type 1 (Gutheil et al., 1994) . Furthermore, DPP IV has been implicated in hepatocyte/extracellular matrix interaction (Piazza et al., 1989) . Although the mechanism remains to be elucidated, it is intriguing that non-structural proteins of HCV expressed in this cell line may be associated with the high expression of CD26 which can mediate signal transduction of hepatocytes. Studies to determine the essential sequence of the HCV genome associated with such upregulation of CD26 are ongoing. Information obtained from these studies may provide clues to understanding the pathophysiology of liver cells infected with HCV.
